dea patient activity report

How do I contact the California Department of Justice patient activity report?

Patient Activity Report (PAR) pdmp CURES California Department of Justice PDMP/CURES P.O. Box 160447 Sacramento, California 95816 Phone: (916) 227- 3843 FAX: (916) 227-4589

What is the purpose of a patient activity report?

CURES Patient Activity Report (PAR)  Prescribing and dispensing history of Schedule II-IV controlled substances.  Registered prescribers and dispensers can quickly review a patient’s controlled substance history.  Enables a prescriber to identify and prevent drug abuse through accurate & rapid tracking.

What schedule of prescription dispensing data does cures report to DOJ?

CURES CURES stores and reports Schedule II, III and IV prescription dispensation data reported by dispensers to DOJ.  Pharmacists are required to report dispensations of Schedules II through IV controlled substances at least weekly.

NOTE: If you witness an event that may lead to immediate threat to human health or safety, you should report it to your local police or law enforcement authority

Use the links below to report what appears to you as a possible violation of controlled substances laws and regulations. Violations including unlawful purchasing of prescription drugs over the Internet, illegal prescription drug sales, illicit drug distribution or extortion scams.

Illicit Drug Distribution or Trafficking

Report illegal sales/distribution of drugs other than prescription drugs (i.e., heroin, cocaine, etc.)

Report Suspicious Online Pharmacies

Report Suspected Unlawful Sales of Pharmaceutical Drugs on the Internet

RX Abuse Online Reporting

Report illegal sales/distribution of prescription drugs (i.e., oxycodone, hydrocodone, etc.); doctors and pharmacies

Synthetic Drug Online Reporting

Report an incident with Synthetic Drugs (i.e., Green Giant, Joker, N-Bomb, Flakka, etc.)

Drug Facts

Browse information on different types of drugs, their street names, how they're used, and how they affect the body.

Drug Scheduling

Learn about the categories used to classify drugs depending on their medical use and their potential for abuse.

Federal Drug Trafficking Penalties

Learn about the federal penalties for drug trafficking in the United States.

Who can provide data to the Department of Justice?

Data may be provided to public or private entities, as approved by the Department of Justice, for educational, peer review, statistical, or research purposes, provided that patient information, including any information that may identify the patient, is not compromised.

What is the purpose of PDMP?

The mission of the California Prescription Drug Monitoring Program ( PDMP) is to eliminate pharmaceutical drug diversion in the state while promoting legitimate medical practice and quality patient care. pdmp.

When are controlled substance prescriptions required to be reported?

Additionally, dispensation reporting for Schedules II-V controlled substance prescriptions are required to be reported not more than one working day after the date a controlled substance is released to a patient or a patient’s representative. The CURES database will reflect updated dispensation information within 24 - 72 hours from the time a dispenser reports the information.

What is the California Department of Justice?

In accordance with California Health & Safety Code section 11165 (c) (2) (A) the California Department of Justice (CA DOJ) may provide CURES data to public or private entities, as approved by the CA DOJ, for educational, peer review, statistical, or research purposes, provided that the patient information, including any information that may identify the patient, is not compromised.

What is the California Health and Safety Code?

California Health & Safety Code Section 11165 (d) requires dispensing pharmacies, clinics, or other dispensers of Schedule II, Schedule III, Schedule IV, and Schedule V controlled substances to provide specified dispensing information to the Department of Justice as soon as reasonably possible, but not more than one working day after the date a controlled substance is released to the patient or patient’s representative, in a format approved and accepted by the DOJ. Currently, the ASAP 2009 Version 4.1 format is accepted.